초록 ▼

An intravaginal therapeutic system for the pre-programmed, unattended delivery of a drug is disclosed. The system comprises (a) a drug, (b) a delivery module comprising a reservoir for storing the drug in an amount for execution of the program, a rate controller which maintains the rate of drug deli

An intravaginal therapeutic system for the pre-programmed, unattended delivery of a drug is disclosed. The system comprises (a) a drug, (b) a delivery module comprising a reservoir for storing the drug in an amount for execution of the program, a rate controller which maintains the rate of drug delivered in a therapeutically effective amount throughout the life of the system, an energy source for transferring drug from the reservoir to the vagina, and a portal for releasing the drug from the module to the vagina, (c) a platform which integrates the module into a unit sized, shaped and adapted for insertion and retention in a vagina, and (d) therapeutic program which provides for the controlled release of drug to produce a beneficial effect over a prolonged period of time.

대표청구항 ▼

A vaginal device adapted and sized for easy insertion and comfortable retention in a vagina, the device comprising: a shaped tube formed of microporous polymer and joined by a coupling inserted into the ends of the tube to form a device with an internal reservoir, said reservoir containing a drug an

A vaginal device adapted and sized for easy insertion and comfortable retention in a vagina, the device comprising: a shaped tube formed of microporous polymer and joined by a coupling inserted into the ends of the tube to form a device with an internal reservoir, said reservoir containing a drug and a carrier for the drug, which drug is released by the device at a controlled rate and in a therapeutically effective amount over a prolonged period of time.